| Home
Research Areas Research Locations Programs |
|
PUBLICATIONS / resources About Media center Events search Contribute |
|
|
Oral Presentations
Microbicides 2008
Striving Towards HIV Prevention
24–27 February 2008
New Delhi, India
| Title | Author(s) | Link |
| "An analysis of varying measures of adherence among women enrolled in the Carraguard® Phase 3 trial" | Sarah A. Littlefield, Marlena Gehret, Barbara Friedland, Robin Maguire, Sumentheran N. Govender, Hlengiwe Vilakazi, N. Carolus, Jasmine Rossier, F. Sibanyoni, J. Modise, Thesla Palanee, Gita Ramjee, Alana de Kock, and Khatija Ahmed | (PDF) |
| "Building the platform for HIV prevention for adolescent girls" |
Martha Brady |
(PDF) |
| "Challenges and results of including 16–17-year-old women in the Carraguard® Phase 3 efficacy trial" | Stephanie Skoler, Barbara Friedland, Marlena Gehret, N. Ngcozela, P. Mthembu, Thesla Palanee, Alana de Kock, Khatija Ahmed, and Mary-Jane Malebo Ratlhagana | (PDF) |
| "Community misunderstandings arising from premature closure of cellulose sulfate trial and scheduled completion of Carraguard trial" | P.N. Mthembu, Thesla Palanee, and Gita Ramjee | (PDF) |
| "A comparison between self-reported condom use and presence of spermatozoa using TV Inpouch and wet mount, among women enrolled in the Phase 3 Carraguard® clinical trial in Cape Town" |
F.P. Gopolang,
Marlena Gehret,
and Lydia Altini |
(PDF) |
| "The contribution of behavioral research to microbicide trials: Taking stock" | Barbara S. Mensch | (PDF) |
| "Establishing the standard of care in HIV prevention trials: Experience of Setshaba Research Centre" |
Khatija Ahmed |
(PDF) |
| "An evaluation of care and support of women who test HIV positive during the Phase 3 Carraguard® trial in South Africa" | Jane Harries, Smruti Patel, Nazira Cassim, Barbara Friedland, Khatija Ahmed, Vuyelwa Mtimkulu, Thesla Palanee, Neetha S. Morar, and C. Milford | (PDF) |
| "Incidence and point prevalence of sexually transmitted and reproductive tract infections among women enrolled in the Phase 3 Carraguard® trial in South Africa" | Thesla Palanee, Marlena Gehret, Stephanie Skoler, Pekka Lähteenmäki, Barbara Friedland, Smruti Patel, Khatija Ahmed, Nazira Cassim, Lydia Altini, Neetha S. Morar, Sumentheran N. Govender, L. Zhou, and Gita Ramjee | (PDF) |
| "Male partner circumcision and HIV seroconversion among participants in the Phase 3 Carraguard® microbicide trial" |
Marlena Gehret, Thesla Palanee, Joseph Skhosana, Barbara Friedland, Sarah Littlefield, Alana de Kock, Nela Williams, and Stephanie Skoler |
(PDF) |
| "Quantification of microbicide HIV-1 anti-infective activity in vitro using an infectious virus titer reduction protocol" |
Tammy T. Evans-Strickfaden,
Nicolas de la Torre, L. Davis Lupo, and Clyde E. Hart |
(PDF) |
Poster Presentations
| Title | Author(s) | Link |
| "Acceptability of Carraguard® vaginal gel among HIV-infected women—Results from a randomized, controlled, crossover trial, Thailand" | Sara J. Whitehead, C.M. McLean, Supaporn Chaikummao, Sarah Braunstein, W. Utaivoravit, Janneke van de Wijgert, Taweesap Siraprapasiri, and Lauri Markowitz | (PDF) |
| "Acceptability of the vaginal microbicide Carraguard® among couples in Chiang Rai, Thailand" | Sarah Martin, Kelly Blanchard, Chomnad Manopaiboon, Supaporn Chaikummao, Kate Schaffer, Barbara Friedland, and Peter H. Kilmarx | (PDF) |
| "Assessing the reporting of adherence and sexual activity in a simulated microbicide trial: Preliminary results from an interview mode experiment in the Phase 3 Carraguard® sites, South Africa" | Barbara Mensch, Paul Hewett, Johanna Rankin, Sarah Littlefield, Sharon Abbott, Khatija Ahmed, Nazira Cassim, Smruti Patel, Vuyelwa Mehlomakulu, Gita Ramjee, Thesla Palanee, Stephanie Skoler, Marlena Gehret, and Sumen Govender | (PDF) |
| "Decision making and the influences of others in the informed consent process: A qualitative investigation in the Phase 3 study of Carraguard®" |
Sharon
Abbott,
Barbara
Friedland, Lauren Katzen, Alana de Kock, Sphiwe Madiba,
and Sheila Cishe |
(PDF) |
| "Ensuring care through adequate referrals and community partnerships for women participating in HIV prevention trials: Experience from the Phase 3 Carraguard® trial in Isipingo, KwaZulu Natal, Durban, South Africa" |
Thesla Palanee
and
Gita Ramjee |
(PDF) |
| "Evaluation of a video to enhance the informed consent process in the Phase 3 Carraguard® trial" | Barbara Friedland, Stephanie Skoler, Alana de Kock, Lauren Katzen, Louis Apicella, Manuela M. Williams, Vuyelwa Mehlomakulu, and Vuyelwa Mtimkulu | (PDF) |
|
"Impact of acceptability on adherence in the Carraguard® Phase
3 trial"
|
Barbara Friedland, Sarah Littlefield, Stephanie Skoler, Alana de Kock, Thesla Palanee, Marlena Gehret, Lauren Katzen, Neetha Morar, Vuyelwa Mehlomakulu, and Manuela M. Williams | (PDF) |
| "Impact of provision of hormonal contraception on pregnancy incidence in women enrolled in the Phase 3 Carraguard® clinical trial at three sites in South Africa" | N. Cele, Thesla Palanee, N. Myeni, N. Mnyandu, Z. Langa, E. Shange, Marlena Gehret, Pekka Lähteenmäki, Stephanie Skoler, Lydia Altini, Smruti Patel, Khatija Ahmed, Nazira Cassim, and Gita Ramjee | (PDF) |
| "Male partner involvement in the Carraguard® Phase 3 trial: Data from a qualitative study of the informed consent process" |
Sphiwe Madiba,
Barbara
Friedland, Sharon Abbott, Lauren Katzen, Alana
de Kock, and Sheila Cishe |
(PDF) |
| "Qualitative evaluation of the informed consent process in the Phase 3 Carraguard® efficacy trial: Study staff experiences and recommendations for future trials" |
Lauren Katzen,
Barbara
Friedland, Sharon Abbott, Alana de Kock, Sphiwe
Madiba, and Sheila Cishe |
(PDF) |
| "Strategies to increase male involvement and product adherence in the Phase 3 Carraguard® trial in Durban, South Africa" |
N.L. Makhanya, Thesla
Palanee, and
Gita Ramjee |
(PDF) |
| "Value of a defined HIV testing algorithm in resolution of discordant and indeterminate results in the Phase 3 Carraguard® trial, South Africa" | Thesla Palanee, Marlena Gehret, Pekka Lähteenmäki, Stephanie Skoler, S. Eghan, Sumentheran N. Govender, Lydia Altini, Khatija Ahmed, and Gita Ramjee | (PDF) |
See Also
-
"A conversation with Mary-Jane Malebo Ratlhagana, microbicides trial community outreach team member, Setshaba Research Centre, Soshanguve, Pretoria" (full text)
-
HIV and AIDS special edition of Population Briefs (PDF)
-
"What are microbicides and
why are they needed?" -
"From bench to bedroom: The Population Council's HIV and AIDS program," fact sheet (PDFs: A4 and letter)
Contact: microbicide@popcouncil.org
Carraguard® is the Population Council's US trademark for pharmaceutical preparations, namely microbicides, for use in preventing infection.
Print this page |
This page updated |